Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1179.96%
operating margin TTM
-1338.54%
revenue TTM
571.28 Thousand
revenue per share TTM
0.43$
valuation ratios | |
|---|---|
| pe ratio | -1.13 |
| peg ratio | -0.03 |
| price to book ratio | 1.10 |
| price to sales ratio | 13.28 |
| enterprise value multiple | -2.17 |
| price fair value | 1.10 |
profitability ratios | |
|---|---|
| gross profit margin | -282.77% |
| operating profit margin | -1338.54% |
| pretax profit margin | -1179.96% |
| net profit margin | -1179.96% |
| return on assets | -77.74% |
| return on equity | -76.24% |
| return on capital employed | -111.24% |
liquidity ratio | |
|---|---|
| current ratio | 4.82 |
| quick ratio | 4.82 |
| cash ratio | 4.55 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 237.30 |
| days of payables outstanding | 56.50 |
| cash conversion cycle | 180.81 |
| receivables turnover | 1.54 |
| payables turnover | 6.46 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | -7.77 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | -21.20 |
| cash per share | 14.67 |
| operating cash flow per share | -21.21 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -2,153.77 |
Frequently Asked Questions
When was the last time Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) reported earnings?
Pieris Pharmaceuticals, Inc. (PIRS) published its most recent earnings results on 13-11-2024.
What is Pieris Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS)'s trailing twelve months ROE is -76.24%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Pieris Pharmaceuticals, Inc. (PIRS) currently has a ROA of -77.74%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PIRS's net profit margin stand at?
PIRS reported a profit margin of -1179.96% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PIRS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.82 in the most recent quarter. The quick ratio stood at 4.82, with a Debt/Eq ratio of 0.00.